For: | Demirtas CO, Brunetto MR. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it? World J Gastroenterol 2021; 27(33): 5536-5554 [PMID: 34588750 DOI: 10.3748/wjg.v27.i33.5536] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v27/i33/5536.htm |
Number | Citing Articles |
1 |
Peter D. Block, Joseph K. Lim. Unmet needs in the clinical management of chronic hepatitis B infection. Journal of the Formosan Medical Association 2024; doi: 10.1016/j.jfma.2024.08.020
|
2 |
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma 2021; : 1579 doi: 10.2147/JHC.S327339
|
3 |
Chao‐Jun Zhang, Xiao‐Mei Chen, Chang Yan, Rui‐Bo Lv, Sanchun An, Yun‐Xin Gao, Tian‐Ren Huang, Wei Deng. HBX Multi‐Mutations Combined With Traditional Screening Indicators to Establish a Nomogram Contributes to Precisely Stratify the High‐Risk Population of Hepatocellular Carcinoma. Cancer Medicine 2025; 14(5) doi: 10.1002/cam4.70748
|
4 |
Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary. Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. Cancers 2024; 16(23): 3933 doi: 10.3390/cancers16233933
|
5 |
Pavithra Ayyadurai, Chinnasamy Ragavendran. Nano-bio-encapsulation of phyto-vaccines: a breakthrough in targeted cancer immunotherapy. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-024-10164-w
|
6 |
Lorenzo Lani, Giacomo Zaccherini, Edoardo G. Giannini, Franco Trevisani. Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?. Hepatoma Research 2025; doi: 10.20517/2394-5079.2024.136
|
7 |
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer. Journal of Hepatocellular Carcinoma 2022; : 221 doi: 10.2147/JHC.S352057
|
8 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
9 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
10 |
Gian Paolo Caviglia, Giulia Troshina, Umberto Santaniello, Giulia Rosati, Francesco Bombaci, Giovanni Birolo, Aurora Nicolosi, Giorgio Maria Saracco, Alessia Ciancio. Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals. Cancers 2022; 14(3): 828 doi: 10.3390/cancers14030828
|
11 |
Piero Colombatto, Barbara Coco, Ferruccio Bonino, Maurizia R. Brunetto. Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine. Viruses 2022; 14(4): 701 doi: 10.3390/v14040701
|
12 |
K. S. Zemlyanukhina, I. N. Tikhonov, M. S. Zharkova, O. Yu. Kiseleva, R. Т. Rzayev, V. T. Ivashkin. Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(4): 104 doi: 10.22416/1382-4376-2024-34-4-104-112
|
13 |
N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev. Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma. Сибирский научный медицинский журнал 2025; 45(1): 6 doi: 10.18699/SSMJ20250101
|
14 |
Erica Villa, Rossella Donghia, Valentina Baldaccini, Calogero C. Tedesco, Endrit Shahini, Raffaele Cozzolongo, Sara Ascari, Pasqua Letizia Pesole, Sergio Coletta, Rosina Maria Critelli, Simone Lasagni, Filippo Schepis, Filippo Semellini, Gianluigi Giannelli. GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000262
|